CS logo
small CS logo
Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States
Hospital in Boston, Massachusetts
330 Brookline Ave, Boston, MA 02215
673 Beds

About Beth Israel Deaconess Medical Center


Beth Israel Deaconess Medical Center in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital and New England Deaconess Hospital.
There are 673 beds in Beth Israel Deaconess Medical Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Beth Israel Deaconess Medical Center
387
Dana-Farber Cancer Institute
183
Massachusetts General Hospital
101
National Cancer Institute (NCI)
96
National Institute of Allergy and Infectious Diseases (NIAID)
68
Gilead Sciences
42
Bristol-Myers Squibb
41
Eastern Cooperative Oncology Group
36
Pfizer
31
Hoffmann-La Roche
27
Boston Scientific Corporation
25
Total Rows: 100

Clinical Trials at Beth Israel Deaconess Medical Center


During the past decade, Beth Israel Deaconess Medical Center conducted 838 clinical trials. In the 10-year time frame, 838 clinical trials started and 572 clinical trials were completed, i.e. on average, 68.3% percent of trials that started reached the finish line to date. In the past 5 years, 285 clinical trials started and 233 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years9797109109118118124124105105124124898963639946465151124124515167676464808062622727Started TrialsCompleted Trails201520162017201820192020202120222023050100150
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
1995-11-01
Completed
2,100
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
1997-09-01
Completed
400
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
1993-05-01
Completed
750
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
1996-02-01
Completed
250
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
Completed
750
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Completed
660
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
1993-11-01
Completed
500

Rows per page:

1–100 of 2023

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center" #1 sponsor was "Beth Israel Deaconess Medical Center" with 387 trials, followed by "Dana-Farber Cancer Institute" with 183 trials sponsored, "Massachusetts General Hospital" with 101 trials sponsored, "National Cancer Institute (NCI)" with 96 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 96 trials sponsored. Other sponsors include 1183 different institutions and companies that sponsored additional 555 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Deaconess Medical Center" #1 collaborator was "Beth Israel Deaconess Medical Center" with 196 trials as a collaborator, "National Cancer Institute (NCI)" with 165 trials as a collaborator, "Brigham and Women's Hospital" with 122 trials as a collaborator, "Massachusetts General Hospital" with 96 trials as a collaborator and "Dana-Farber Cancer Institute" with 59 trials as a collaborator. Other collaborators include 1784 different institutions and companies that were collaborators in the rest 696 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBeth Israel DeaconessMedical Center: 387Beth Israel DeaconessMedical Center: 387Dana-Farber CancerInstitute: 183Dana-Farber CancerInstitute: 183Massachusetts GeneralHospital: 101Massachusetts GeneralHospital: 101National CancerInstitute (NCI): 96National CancerInstitute (NCI): 96National Institute ofAllergy and InfectiousDiseases (NIAID): 68National Institute ofAllergy and InfectiousDiseases (NIAID): 68Gilead Sciences: 42Gilead Sciences: 42Bristol-Myers Squibb: 41Bristol-Myers Squibb: 41Eastern CooperativeOncology Group: 36Eastern CooperativeOncology Group: 36Pfizer: 31Pfizer: 31Hoffmann-La Roche: 27Hoffmann-La Roche: 27

Created with Highcharts 11.1.0Top CollaboratorsBeth Israel DeaconessMedical Center: 196Beth Israel DeaconessMedical Center: 196National CancerInstitute (NCI): 165National CancerInstitute (NCI): 165Brigham and Women'sHospital: 122Brigham and Women'sHospital: 122Massachusetts GeneralHospital: 96Massachusetts GeneralHospital: 96Dana-Farber Cancer Institute: 59Dana-Farber Cancer Institute: 59Genentech, Inc.: 52Genentech, Inc.: 52National Heart, Lung,and Blood Institute(NHLBI): 50National Heart, Lung,and Blood Institute(NHLBI): 50Bristol-Myers Squibb: 42Bristol-Myers Squibb: 42National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 29National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 29National Institutes ofHealth (NIH): 28National Institutes ofHealth (NIH): 28

Clinical Trials Conditions at Beth Israel Deaconess Medical Center


According to Clinical.Site data, the most researched conditions in "Beth Israel Deaconess Medical Center" are "Breast Cancer" (95 trials), "HIV Infections" (94 trials), "Prostate Cancer" (57 trials), "Multiple Myeloma" (47 trials) and "Lung Cancer" (32 trials). Many other conditions were trialed in "Beth Israel Deaconess Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Beth Israel Deaconess Medical Center


Most popular intervention types in "Beth Israel Deaconess Medical Center" are "Drug" (1276 trials), "Other" (272 trials), "Biological" (250 trials), "Device" (243 trials) and "Procedure" (148 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (197 trials), "Nivolumab" (54 trials), "Laboratory Biomarker Analysis" (51 trials), "Bevacizumab" (43 trials) and "Paclitaxel" (35 trials). Other intervention names were less common.

Clinical Trials Genders at Beth Israel Deaconess Medical Center


The vast majority of trials in "Beth Israel Deaconess Medical Center" are 1796 trials for "All" genders, 148 trials for "Female" genders and 79 trials for "Male" genders.

Clinical Trials Status at Beth Israel Deaconess Medical Center


Currently, there are 567 active trials in "Beth Israel Deaconess Medical Center". 8 are not yet recruiting, 271 are recruiting, 281 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 1129 completed trials in Beth Israel Deaconess Medical Center, 9 suspended trials, and 211 terminated clinical trials to date.
Out of the total trials that were conducted in Beth Israel Deaconess Medical Center, 334 "Phase 1" clinical trials were conducted, 778 "Phase 2" clinical trials and 395 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 387 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 778Phase 2: 778Phase 3: 395Phase 3: 395Not Applicable: 387Not Applicable: 387Phase 1: 334Phase 1: 334Phase 4: 53Phase 4: 53Early Phase 1: 10Early Phase 1: 10

Created with Highcharts 11.1.0Trials StatusCompleted: 1129Completed: 1129Active, not recruiting: 281Active, not recruiting: 281Recruiting: 271Recruiting: 271Terminated: 211Terminated: 211Unknown status: 59Unknown status: 59Withdrawn: 43Withdrawn: 43Suspended: 9Suspended: 9Not yet recruiting: 8Not yet recruiting: 8Enrolling by invitation: 7Enrolling by invitation: 7No longer available: 3No longer available: 3

Departments of Beth Israel Deaconess Medical Center


Beth Israel Deaconess Medical Center has several departments that took part in Clinical trials: "Beth Israel Deaconess Med Ctr; Hem/Onc" - 4 trials, "Beth Israel Comprehensive Cancer Center" - 4 trials, "Beth Israel Deaconess Medical Center, Harvard Medical School; Department of Medicine" - 3 trials, "Beth Israel Deaconess Med Ctr; Neurology/MS Center" - 3 trials, "Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center" - 3 trials, "Beth Israel Deaconess Medical Center/ Massachusetts Mental Health Center" - 2 trials, "Pain Clinic at Beth Israel Deaconess Medical Center" - 2 trials, "Douglas Plesko" - 2 trials